MultiPlan Corporation reported Q2 2024 financial results with revenues of $233.5 million, a net loss of $576.7 million (including a $553.7 million impairment of goodwill), and an adjusted EBITDA of $146.7 million. The company updated its full-year 2024 guidance, lowering revenue and adjusted EBITDA expectations.
Revenues for Q2 2024 were $233.5 million, a 1.9% decrease compared to Q2 2023.
Net loss for Q2 2024 was $576.7 million, primarily due to a $553.7 million goodwill impairment charge.
Adjusted EBITDA for Q2 2024 was $146.7 million, compared to $152.7 million for Q2 2023.
Identified potential medical cost savings of approximately $6.2 billion in Q2 2024, up 9% from Q2 2023.
The Company is updating its full-year 2024 guidance. The Company anticipates Q3 2024 revenues between $230 million and $245 million and Adjusted EBITDA between $140 million to $150 million.
Analyze how earnings announcements historically affect stock price performance